Recent Finacing
Recent Raise
SolaranRx develops a precision theranostic platform for metastatic melanoma, using SRX-1177, an MC1-targeted peptide–radioisotope that images MC1-positive tumors then delivers targeted radiotherapy.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor